BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 17927714)

  • 1. Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease.
    Hoevenaren IA; Wester R; Schrier RW; McFann K; Doctor RB; Drenth JP; Everson GT
    Liver Int; 2008 Feb; 28(2):264-70. PubMed ID: 17927714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort.
    Bae KT; Zhu F; Chapman AB; Torres VE; Grantham JJ; Guay-Woodford LM; Baumgarten DA; King BF; Wetzel LH; Kenney PJ; Brummer ME; Bennett WM; Klahr S; Meyers CM; Zhang X; Thompson PA; Miller JP;
    Clin J Am Soc Nephrol; 2006 Jan; 1(1):64-9. PubMed ID: 17699192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications of autosomal dominant polycystic kidney disease in 50 haemodialysed patients. A case-control study. The U.C.L. Collaborative Group.
    Christophe JL; van Ypersele de Strihou C; Pirson Y
    Nephrol Dial Transplant; 1996 Jul; 11(7):1271-6. PubMed ID: 8672022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Two cases of autosomal dominant polycystic kidney disease treated with hemodialysis associated with polycystic liver complications related to the cause of death].
    Saima S; Suzuki Y; Yoshimoto K; Nakamura Y; Munakata A
    Nihon Jinzo Gakkai Shi; 1996 Jun; 38(6):278-84. PubMed ID: 8752971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autosomal dominant polycystic kidney disease: MR imaging evaluation using current techniques.
    Mosetti MA; Leonardou P; Motohara T; Kanematsu M; Armao D; Semelka RC
    J Magn Reson Imaging; 2003 Aug; 18(2):210-5. PubMed ID: 12884334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidemiologic data, clinical and prognostic features of autosomal dominant polycystic kidney disease in a French region].
    Simon P; Le Goff JY; Ang KS; Charasse C; Le Cacheux P; Cam G
    Nephrologie; 1996; 17(2):123-30. PubMed ID: 8838759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New therapeutic option for autosomal dominant polycystic kidney disease patients with enlarged kidney and liver.
    Ubara Y
    Ther Apher Dial; 2006 Aug; 10(4):333-41. PubMed ID: 16911186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autosomal-dominant polycystic kidney disease and kidney transplantation: experience of a single center.
    Gonçalves S; Guerra J; Santana A; Abreu F; Mil-Homens C; Gomes da Costa A
    Transplant Proc; 2009 Apr; 41(3):887-90. PubMed ID: 19376380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravascular embolization therapy in patients with enlarged polycystic liver.
    Hoshino J; Ubara Y; Suwabe T; Sumida K; Hayami N; Mise K; Hiramatsu R; Hasegawa E; Yamanouchi M; Sawa N; Takei R; Takaichi K
    Am J Kidney Dis; 2014 Jun; 63(6):937-44. PubMed ID: 24602778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbohydrate antigen 19-9 as a diagnostic marker for hepatic cyst infection in autosomal dominant polycystic kidney disease.
    Kanaan N; Goffin E; Pirson Y; Devuyst O; Hassoun Z
    Am J Kidney Dis; 2010 May; 55(5):916-22. PubMed ID: 20189277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of kidney transplantation in patients with polycystic kidney disease: a single center study.
    Roozbeh J; Razmkon AR; Jalaeian H; Raiss-Jalali GA; Behzadi S; Sagheb MM; Salahi H; Bahador A; Nikeghbalian S; Davari HR; Salehipour M; Malek-Hosseini SA
    Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):72-5. PubMed ID: 18087127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
    Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K
    Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal hepatocystin caused by truncating PRKCSH mutations leads to autosomal dominant polycystic liver disease.
    Drenth JP; Tahvanainen E; te Morsche RH; Tahvanainen P; Kääriäinen H; Höckerstedt K; van de Kamp JM; Breuning MH; Jansen JB
    Hepatology; 2004 Apr; 39(4):924-31. PubMed ID: 15057895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic removal of renal cysts in patients with ADPKD as an alternative method of treatment and patient preparation for kidney transplantation: preliminary results.
    Sulikowski T; Kamiński M; Rózański J; Zietek Z; Domański L; Majewski W; Sieńko J; Romanowski M; Mizerski A; Myślak M; Tejchman K; Pabisiak K; Nowacki M; Ostrowski M; Ciechanowski K
    Transplant Proc; 2006; 38(1):23-7. PubMed ID: 16504654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [From gene to disease; hepatocystin and autosomal dominant polycystic liver disease].
    Jansen JB; Morsche RH; Drenth JP
    Ned Tijdschr Geneeskd; 2003 Jul; 147(29):1408-12. PubMed ID: 12894465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Everolimus does not further reduce polycystic liver volume when added to long acting octreotide: results from a randomized controlled trial.
    Chrispijn M; Gevers TJ; Hol JC; Monshouwer R; Dekker HM; Drenth JP
    J Hepatol; 2013 Jul; 59(1):153-9. PubMed ID: 23499726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infected hepatic and renal cysts: differential impact on outcome in autosomal dominant polycystic kidney disease.
    Suwabe T; Ubara Y; Higa Y; Nakanishi S; Sogawa Y; Nomura K; Nishimura H; Hoshino J; Sawa N; Katori H; Takemoto F; Nakamura M; Tomikawa S; Hara S; Takaichi K
    Nephron Clin Pract; 2009; 112(3):c157-63. PubMed ID: 19390216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretion of cytokines and growth factors into autosomal dominant polycystic kidney disease liver cyst fluid.
    Nichols MT; Gidey E; Matzakos T; Dahl R; Stiegmann G; Shah RJ; Grantham JJ; Fitz JG; Doctor RB
    Hepatology; 2004 Oct; 40(4):836-46. PubMed ID: 15382115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycystic liver and kidney diseases.
    Tahvanainen E; Tahvanainen P; Kääriäinen H; Höckerstedt K
    Ann Med; 2005; 37(8):546-55. PubMed ID: 16338757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with autosomal dominant polycystic kidney disease in patients before and after renal transplantation: a 7-year observation.
    Sulikowski T; Tejchman K; Zietek Z; Rózański J; Domański L; Kamiński M; Sieńko J; Romanowski M; Nowacki M; Pabisiak K; Kaczmarczyk M; Ciechanowski K; Ciechanowicz A; Ostrowski M
    Transplant Proc; 2009; 41(1):177-80. PubMed ID: 19249508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.